CSIMarket
 


Abbott Laboratories  (ABT)
Other Ticker:  
 
 

ABT's Revenue Growth by Quarter and Year

Abbott Laboratories's Revenue results by quarter and year




ABT Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 10,701.00 8,314.00 7,765.00
III Quarter September - 8,853.00 8,076.00 7,656.00
II Quarter June - 7,328.00 7,979.00 7,767.00
I Quarter March 10,456.00 7,726.00 7,535.00 7,390.00
FY   10,456.00 34,608.00 31,904.00 30,578.00



ABT Revenue first quarter 2021 Y/Y Growth Comment
Abbott Laboratories achieved in the first quarter, above Company average Revenue growth of 35.34% year on year, to $ 10,456.00 millions.

Looking into first quarter results within Major Pharmaceutical Preparations industry 51 other companies have achieved higher Revenue growth. While Abbott Laboratories' s Revenue rise of 35.34% ranks overall at the positon no. 642 in the first quarter.




ABT Revenue ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - 28.71 % 7.07 % 2.32 %
III Quarter September - 9.62 % 5.49 % 12.11 %
II Quarter June - -8.16 % 2.73 % 17.03 %
I Quarter March 35.34 % 2.53 % 1.96 % 16.65 %
FY   - 8.48 % 4.34 % 11.64 %

Financial Statements
Abbott Laboratories's first quarter 2021 Revenue $ 10,456.00 millions ABT's Income Statement
Abbott Laboratories's first quarter 2020 Revenue $ 7,726.00 millions Quarterly ABT's Income Statement
New: More ABT's historic Revenue Growth >>


ABT Revenue (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 20.87 % 2.95 % 1.42 %
III Quarter September - 20.81 % 1.22 % -1.43 %
II Quarter June - -5.15 % 5.89 % 5.1 %
I Quarter March -2.29 % -7.07 % -2.96 % -2.62 %
FY (Year on Year)   - 8.48 % 4.34 % 11.64 %




Revenue first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #52
Healthcare Sector #131
Overall #642

Revenue Y/Y Growth Statistics
High Average Low
42.3 % 5.53 % -47.82 %
(Dec 31 2017)   (Dec 31 2013)
Revenue first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #52
Healthcare Sector #131
Overall #642
Revenue Y/Y Growth Statistics
High Average Low
42.3 % 5.53 % -47.82 %
(Dec 31 2017)   (Dec 31 2013)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Abbott Laboratories's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
85.61 % 2.21 % -50.37 %
(June 30. 2012)  


ABT's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2021 Abbott Laboratories realized fall in Revenue sequentially by -2.29% to $ 10,456.00 millions, from $ 10,701.00 millions declared in the previous reporting period.

This is not big problem, as Revenue always gravitate to slow in this quarter Ruby  V. Green, a business insider located in Dublin wrote.

Within Major Pharmaceutical Preparations industry 60 other companies have achieved higher Revenue quarter on quarter growth. While Abbott Laboratories's Revenue growth quarter on quarter, overall rank is 1675.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #61
Healthcare Sector #191
Overall #1675
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #61
Healthcare Sector #191
Overall #1675
Revenue Q/Q Growth Statistics
High Average Low
85.61 % 2.21 % -50.37 %
(June 30. 2012)  


ABT's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2021 Abbott Laboratories reported fall in Revenue from the forth quarter by -2.29% to $ 10,456.00 millions, from $ 10,701.00 millions released in the previous quarter.

It's not important problem, as Abbott Laboratories's Revenue always seem to plunge in the I. Quarter.

Within Major Pharmaceutical Preparations industry 60 other companies have achieved higher Revenue quarter on quarter growth. While Abbott Laboratories's Revenue growth quarter on quarter, overall rank is 1675.


Abbott Laboratories's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Revenue 12 Months Ending $ 37,338.00 $ 34,608.00 $ 32,221.00 $ 31,444.00 $ 32,095.00
Y / Y Revenue Growth (TTM) 16.34 % 8.48 % 2.76 % 1.65 % 4.47 %
Year on Year Revenue Growth Overall Ranking # 713 # 1131 # 1455 # 1579 # 1541
Seqeuential Revenue Change (TTM) 7.89 % 7.41 % 2.47 % -2.03 % 0.6 %
Seq. Revenue Growth (TTM) Overall Ranking # 234 # 822 # 1268 # 1927 # 1548




Cumulative Revenue growth Comment
Abbott Laboratories saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 16.34% year on year, to $ 37,338 millions if the fiscal year would have ended in Mar 31 2021.
Abbott Laboratories's trailing twelve months Revenue growth was higher than company's average 4.73% and higher than 8.48% growth in Dec 31 2020.
But from twelve months ended Dec 31 2020 growth rate was beneth at 7.89 % from $34608 millions recorded in twelve months ending a quarter Dec 31 2020 Ruby  V. Green added on.
Yet it was confirmation of strength, while the usual sequential Revenue growth stands at 0.11%.
The growth is even stronger from the previous reporting period showed at 7.89 % jump from $34608 millions in the period from Dec 31 2020 to Mar 31 2020.

In the Healthcare sector 158 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 713, from total ranking in previous quarter at 1131.

Revenue TTM Q/Q Growth Statistics
High Average Low
8.98 %
0.11 %
-56.84 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 15
Healthcare Sector # 159
Overall # 713

Revenue TTM Y/Y Growth Statistics
High Average Low
31.35 %
4.73 %
-39.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 15
Sector # 42
S&P 500 # 234
Cumulative Revenue growth Comment
Abbott Laboratories saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 16.34% year on year, to $ 37,338 millions if the fiscal year would have ended in Mar 31 2021.
Abbott Laboratories's trailing twelve months Revenue growth was higher than company's average 4.73% and higher than 8.48% growth in Dec 31 2020.
But sequential rise was slower at 7.89 % from $34608 millions recorded in the period from Dec 31 2020 to Mar 31 2020.
Yet it was confirmation of convincing trend, as the typical sequential Revenue gain lays at 0.11%.
The progress was even stronger from twelve months ended Dec 31 2020 showed at 7.89 % increase from $34608 millions in twelve months ending a quarter before.

In the Healthcare sector 158 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 713, from total ranking in previous quarter at 1131.

Revenue TTM Q/Q Growth Statistics
High Average Low
8.98 %
0.11 %
-56.84 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 15
Healthcare Sector # 159
Overall # 713

Revenue TTM Y/Y Growth Statistics
High Average Low
31.35 %
4.73 %
-39.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 15
Sector # 42
S&P 500 # 234




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ABT's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ABT's Competitors
Revenue Growth for Abbott Laboratories's Suppliers
Revenue Growth for ABT's Customers

You may also want to know
ABT's Annual Growth Rates ABT's Profitability Ratios ABT's Asset Turnover Ratio ABT's Dividend Growth
ABT's Roe ABT's Valuation Ratios ABT's Financial Strength Ratios ABT's Dividend Payout Ratio
ABT's Roa ABT's Inventory Turnover Ratio ABT's Growth Rates ABT's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2021
Twist Bioscience Corporation61.70%$ 61.704 millions
Milestone Scientific Inc 61.46%$ 61.462 millions
Invitae Corp61.28%$ 61.283 millions
Bicycle Therapeutics Plc60.14%$ 60.142 millions
Zynex Inc58.44%$ 58.438 millions
Tela Bio Inc 57.73%$ 57.729 millions
Fibrogen Inc 57.49%$ 57.489 millions
Adma Biologics Inc 57.34%$ 57.343 millions
Regional Health Properties Inc 55.69%$ 55.695 millions
Cutera Inc54.06%$ 54.062 millions
Surmodics Inc 53.34%$ 53.339 millions
Abbvie Inc 50.95%$ 50.946 millions
Progyny Inc 50.74%$ 50.737 millions
Precipio Inc 50.00%$ 50.000 millions
Stereotaxis Inc 49.79%$ 49.795 millions
Quest Diagnostics Inc49.29%$ 49.286 millions
Meridian Bioscience Inc 48.81%$ 48.813 millions
Intricon Corporation47.74%$ 47.738 millions
Laboratory Corporation Of America Holdings47.37%$ 47.372 millions
10x Genomics Inc 47.17%$ 47.168 millions
Alphatec Holdings Inc 46.51%$ 46.508 millions
Dyadic International Inc46.02%$ 46.024 millions
Rigel Pharmaceuticals Inc45.30%$ 45.295 millions
Tandem Diabetes Care Inc 44.02%$ 44.024 millions
Hookipa Pharma Inc 43.43%$ 43.425 millions
Sanara Medtech Inc 42.14%$ 42.139 millions
Arbutus Biopharma Corp41.72%$ 41.717 millions
Intelgenx Technologies Corp 41.58%$ 41.584 millions
Seagen Inc 41.56%$ 41.562 millions
Resmed Inc 40.27%$ 40.275 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

UAMY's Profile

Stock Price

UAMY's Financials

Business Description

Fundamentals

Charts & Quotes

UAMY's News

Suppliers

UAMY's Competitors

Customers & Markets

Economic Indicators

UAMY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071